LakeShore Biopharma Co., Ltd. (LSBCF, LSBWF)

CIK 1946399 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for LakeShore Biopharma Co., Ltd..

Recent SEC filings

FiledFormAccession number
Jun 25, 2026SCHEDULE 13D/A0001213900-26-071708
Jun 24, 2026SC 13E3/A0001213900-26-071392
Jun 24, 20266-K0001213900-26-071390
Jun 24, 2026S-8 POS0001213900-26-071393
Jun 24, 2026S-8 POS0001213900-26-071395
Jun 24, 202615-12G0001213900-26-071396
Jun 22, 20266-K0001213900-26-070363
May 28, 2026SC 13E3/A0001213900-26-061798
May 28, 20266-K0001213900-26-061817
May 8, 2026SC 13E3/A0001213900-26-053596
Apr 29, 20266-K0001213900-26-048850
Apr 29, 2026SCHEDULE 13D/A0001213900-26-048876
Apr 10, 202630001213900-26-042181
Apr 10, 202630001213900-26-042186
Apr 1, 202630001213900-26-038111
Apr 1, 202630001213900-26-038108
Apr 1, 2026SC 13E3/A0001213900-26-038038
Apr 1, 202630001213900-26-038110
Apr 1, 202630001213900-26-038112
Mar 31, 202630001213900-26-036799
Mar 25, 20266-K0001213900-26-033849
Mar 25, 2026SCHEDULE 13D/A0001213900-26-033839
Feb 6, 20266-K0001213900-26-013010
Feb 6, 2026SC 13E3/A0001213900-26-013012
Feb 5, 2026SCHEDULE 13D/A0001213900-26-012546